{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:57:48Z","timestamp":1780559868703,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12094-015-1342-7","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T09:12:27Z","timestamp":1446541947000},"page":"99-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma"],"prefix":"10.1007","volume":"18","author":[{"given":"E.","family":"Almagro-Casado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"P\u00e9rez-Callejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Provencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"key":"1342_CR1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1987.5.1.27","volume":"5","author":"A Santoro","year":"1987","unstructured":"Santoro A, Bonadonna G, Valagussa P, Zucali R, Viviani S, Villani F, et al. Long term results of combined chemotherapy-radiotherapy approach in Hodgkin disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol. 1987;5:27\u201337.","journal-title":"J Clin Oncol"},{"key":"1342_CR2","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199211193272102","volume":"327","author":"GP Canellos","year":"1992","unstructured":"Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, et al. Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD or MOPP alternating with ABVD. N England J Med. 1992;327:1498.","journal-title":"N England J Med"},{"issue":"27","key":"1342_CR3","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1200\/JCO.2010.29.8018","volume":"28","author":"HT Eich","year":"2010","unstructured":"Eich HT, Diehl V, Goergen H, Pabst T, Markova J, Debus J, et al. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin\u2019s lymphoma: final analysis of the German Hodgkin Study Group HD11 Trial. J Clin Oncol. 2010;28(27):4199\u2013206.","journal-title":"J Clin Oncol"},{"issue":"7","key":"1342_CR4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","volume":"363","author":"A Engert","year":"2010","unstructured":"Engert A, Pl\u00fctschow A, Eich HT, Lohri A, D\u00f6rken B, Borchmann P, et al. Reduced treatment intensity in patients with early stage Hodgkin lymphoma. N Engl J Med. 2010;363(7):640\u201352.","journal-title":"N Engl J Med"},{"key":"1342_CR5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11912-010-0123-2","volume":"12","author":"SS Baxi","year":"2010","unstructured":"Baxi SS, Matasar MJ. State-of-the-art issues in Hodgkin\u2019s lymphoma survivorship. Curr Oncol Rep. 2010;12:366\u201373.","journal-title":"Curr Oncol Rep"},{"key":"1342_CR6","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","volume":"21","author":"BM Aleman","year":"2003","unstructured":"Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van\u2019t Veer MB, Bartelink H, van Leeuwen FE. Long-term causes-specific mortality of patients treated for Hodgkin\u2019s disease. J Clin Oncol. 2003;21:3431\u20139.","journal-title":"J Clin Oncol"},{"key":"1342_CR7","first-page":"758","volume":"17","author":"M Henry-Amar","year":"1990","unstructured":"Henry-Amar M, Somers R. Survival outcome after Hodgkin\u2019s disease: a report from the international data base on Hodgkin\u2019s disease. Semin Oncol. 1990;17:758\u201368.","journal-title":"Semin Oncol"},{"key":"1342_CR8","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1023\/A:1008306702211","volume":"10","author":"M Provencio","year":"1999","unstructured":"Provencio M, Garc\u00eda-L\u00f3pez FJ, Bonilla F, Espa\u00f1a P. Comparison of the long-term mortality in Hodgkin\u2019s disease patients with that of general population. Ann Oncol. 1999;10:1199\u2013205.","journal-title":"Ann Oncol"},{"issue":"16","key":"1342_CR9","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1158\/1078-0432.CCR-07-0927","volume":"14","author":"M Provencio","year":"2008","unstructured":"Provencio M, Mill\u00e1n I, Espa\u00f1a P, S\u00e1nchez AC, S\u00e1nchez JJ, Cantos B, et al. Analysis of competing risks of causes of death and their variation over different time periods in Hodgkin\u2019s disease. Clin Cancer Res. 2008;14(16):5300\u20135.","journal-title":"Clin Cancer Res"},{"key":"1342_CR10","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1158\/1078-0432.CCR-08-3224","volume":"15","author":"Y Lorenzo","year":"2009","unstructured":"Lorenzo Y, Provencio M, Lombard\u00eda L, D\u00edaz R, Silva J, Herrera M, et al. Differential Genetic and functional markers of second neoplasias in Hodgkin\u2019s disease patients. Clin Cancer Res. 2009;15:4823\u20138.","journal-title":"Clin Cancer Res"},{"key":"1342_CR11","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin\u2019s disease staging classification. Cancer Res. 1971;31:1860\u20131.","journal-title":"Cancer Res"},{"key":"1342_CR12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: cotswolds meeting. J Clin Oncol. 1989;7:1630\u20136.","journal-title":"J Clin Oncol"},{"key":"1342_CR13","first-page":"1268","volume":"26","author":"HS Kaplan","year":"1966","unstructured":"Kaplan HS, Rosenberg SA. Extended field radical radiotherapy in advanced Hodgkin\u2019s disease. Cancer Res. 1966;26:1268\u201376.","journal-title":"Cancer Res"},{"key":"1342_CR14","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO.1990.8.7.1148","volume":"8","author":"JM Andrieu","year":"1990","unstructured":"Andrieu JM, Ifrah N, Payen C, Fermanian J, Coscas Y, Flandrin G. Increased risk of secondary acute non lymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin\u2019s disease. J Clin Oncol. 1990;8:1148\u201354.","journal-title":"J Clin Oncol"},{"key":"1342_CR15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471\u20134.","journal-title":"Ann Surg Oncol"},{"key":"1342_CR16","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","volume":"16","author":"G Dores","year":"2002","unstructured":"Dores G, Metayer C, Curtis R, Lynch CF, Clarke EA, Glimelius B, et al. Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population based evaluation over 25\u00a0years. J Clin Oncol. 2002;16:3484\u201392.","journal-title":"J Clin Oncol"},{"key":"1342_CR17","doi-asserted-by":"crossref","unstructured":"Gilbert ES, Stovall M, Gospodarowicz M, Van Leeuwen FE, Andersson M, Glimelius B,et al. Lung cancer after treatment for Hodgkin\u2019s disease: focus on radiation effects. Radiat Res 2003;159:161\u201373.","DOI":"10.1667\/0033-7587(2003)159[0161:LCATFH]2.0.CO;2"},{"key":"1342_CR18","first-page":"695","volume":"163","author":"LB Travis","year":"2005","unstructured":"Travis LB, Gilbert E. Lung Cancer after Hodgkin lymphoma: the roles of chemotherapy, radiotherapy and tobacco use. Radiat Res. 2005;163:695\u20136.","journal-title":"Radiat Res"},{"key":"1342_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.critrevonc.2011.01.005","volume":"81","author":"B Cutuli","year":"2012","unstructured":"Cutuli B, Kanoun S, Tunon De Lara C, Baron M, Livi L, Levy C, et al. Breast cancer occurred after Hodgkin\u2019s disease: clinico-pathological features, treatments and outcome: Analysis of 214 cases. Crit Rev Oncol Hematol. 2012;81:29\u201337.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1342_CR20","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1200\/JCO.2001.19.6.1610","volume":"19","author":"AJ Swerdlow","year":"2001","unstructured":"Swerdlow AJ, Schoemaker MJ, Allerton R, Horwich A, Barber JA, Cunningham D, et al. Lung cancer after Hodgkin\u2019s disease: a nested case-controlled study of the relation to treatment. J Clin Oncol. 2001;19:1610\u20138.","journal-title":"J Clin Oncol"},{"key":"1342_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000322396","volume":"43","author":"JA Purdy","year":"2011","unstructured":"Purdy JA. Advances in the planning and delivery of radiotherapy: new expectations, new standards of care. Front Radiat Ther Oncol. 2011;43:1\u201328.","journal-title":"Front Radiat Ther Oncol"},{"issue":"4","key":"1342_CR22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2014;89(4):854\u201362. doi: 10.1016\/j.ijrobp.2013.05.005 (Epub 2013 Jun 18).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1342_CR23","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.23081","volume":"110","author":"DC Hodgson","year":"2007","unstructured":"Hodgson DC, Koh E-S, Tran TH, Heydarian M, Tsang R, Pintilie M, et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Cancer. 2007;110:2576\u201386.","journal-title":"Cancer"},{"key":"1342_CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00408-012-9418-4","volume":"191","author":"MI Ezzeldin","year":"2013","unstructured":"Ezzeldin MI, Ghieth AK, Khaled MA, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, et al. Risk of second lung cancer in Hodgkin\u2019s lymphoma survivors: a meta-analysis. Lung. 2013;191:117\u201334.","journal-title":"Lung"},{"key":"1342_CR25","unstructured":"Milano MT, Huilin Li, Constine LS, Travis LB. Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin\u2019s lymphoma patients. J Thorac Dis 2011;4:22\u201329."},{"key":"1342_CR26","first-page":"1027","volume":"9","author":"C Behrens","year":"2000","unstructured":"Behrens C, Travis LB, Wistuba II, Davis S, Maitra A, Clarke EA, et al. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin\u2019s disease. Cancer Epidemiol Biomarkers Prev. 2000;9:1027\u201335.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"1342_CR27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","volume":"12","author":"MJ Hayat","year":"2007","unstructured":"Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) Program. Oncologist. 2007;12(1):20\u201337.","journal-title":"Oncologist"},{"key":"1342_CR28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910520502","volume":"52","author":"JM Kaldor","year":"1992","unstructured":"Kaldor JM, Day NE, Bell J, Langmark F, Karjalainen S, Band P, et al. Lung cancer following Hodgkin\u2019s disease: a case-control study. Int J Cancer. 1992;52:677\u201381.","journal-title":"Int J Cancer"},{"key":"1342_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cncr.10628","volume":"95","author":"SA Laurie","year":"2002","unstructured":"Laurie SA, Kris MG, Portlock CS, Rosenzweig KE, Miller VA, Krug LM, et al. The clinical course of non small cell lung carcinoma in survivors of Hodgkin disease. Cancer. 2002;95:119\u201326.","journal-title":"Cancer"},{"issue":"7","key":"1342_CR30","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/annonc\/mdr551","volume":"23","author":"JD Schoenfeld","year":"2012","unstructured":"Schoenfeld JD, Mauch PM, Das P, Silver B, Marcus KJ, Stevenson MA, et al. Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome. Annals of Oncology 2012;23(7):1813\u20138.","journal-title":"Annals of Oncology"},{"key":"1342_CR31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"National Lung Screening Trial Research Team","year":"2011","unstructured":"Team National Lung Screening Trial Research, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395\u2013409.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1342-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-015-1342-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1342-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:51:45Z","timestamp":1559447505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-015-1342-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s12094-015-1342-7","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]}}}